As the pharmaceutical industry advances toward more patient-centric therapies, complex dosage forms are being shaped not only by formulation science but also by manufacturing innovation. Technologies that improve dosing flexibility, administration, and patient experience are becoming increasingly important.

Pharmaceutical 3D printing (3DP) has evolved into a proven platform for complex dosage forms. Aprecia’s first FDA-approved 3D printed medicine helped validate additive manufacturing as a commercial pharmaceutical technology. As regulators place greater emphasis on patient-centric drug development and real-world usability, 3DP is gaining attention for its ability to support innovative dosage forms, flexible dosing, and improved administration.

A New Era for Complex Dosage Forms

Historically, pharmaceutical manufacturing was considered the final step in bringing a drug to market: a means of scaling a successful formulation. Today, however, manufacturing is becoming part of the clinical and commercial strategy.

Pharmaceutical 3DP offers an alternative approach.

By building dosage forms layer by layer from digital designs, additive manufacturing enables a level of flexibility difficult to achieve with conventional tablet compression processes. Developers can…